Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis

              Author:Arnold, Douglas L.   Freeman, Leorah   Hartung, Hans-Peter   Montalbán, Xavier   Cohen, Jeffrey A.   Bar-Or, Amit   Steinman, Lawrence   DeLuca, John   Cheng, Chun-Yen   Riolo, Jon V.   Silva, Diego   Pachai, Chahin   Cree, Bruce A. C.   

              Session Name:P5: MS Prognosis/Epidemiology  

              Topic:MS and Inflammatory Disease  

              Program Number:P5.010  

              Author Institution:NeuroRx Research and Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada, Montréal, QC, Canada  Dell Medical School, The University of Texas at Austin, Austin, Texas, Austin, TX  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Australia  Department of Neurology, Medical University of Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic  Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, PA  Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, Stanford, CA  Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, Newark, NJ  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA  

              Effects of Ozanimod on Cognitive Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials

              Author:DeLuca, John   Cohen, Jeffrey A.   Cree, Bruce A. C.   Cheng, Chun-Yen   Sheffield, James K.   Riolo, Jon V.   Silva, Diego   Comi, Giancarlo   Kappos, Ludwig   

              Session Name:P6: MS Clinical Trials  

              Topic:MS and Inflammatory Disease  

              Program Number:P6.001  

              Author Institution:Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, West Orange, NJ  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, San Francisco, CA  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Vita-Salute San Raffaele University, and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  

              Abnormal Thalamic Functional Connectivity Correlates With Cardiorespiratory Fitness and Physical Activity in Progressive Multiple Sclerosis

              Author:Romanò, Francesco   Rocca, Maria   Valsasina, Paola   Morozumi, Tetsu   Amato, Maria   Brichetto, Giampaolo   Bruschi, Nicolò   Chataway, Jeremy   Chiaravalloti, Nancy   Cutter, Gary   Dalgas, Ulrik   DeLuca, John   Farrell, Rachel   Feys, Peter   Freeman, Jennifer   Inglese, Maria Matilde   Meza, Cecilia   Salter, Amber   Sandroff, Brian M   Feinstein, Anthony   Motl, Robert   Filippi, Massimo   

              Session Name:P12: Neuro-rehabilitation  

              Topic:Neuro-rehabilitation  

              Program Number:P12.011  

              Author Institution:IRCCS San Raffaele Scientific Institute, Milano, Italy  IRCCS San Raffaele Scientific Institute  Vita-Salute San Raffaele Unviersity, Milan, Italy  University of Florence, Firenze, Italy  Italian MS Society, Genoa, Italy  University of Genoa, Genoa, Italy  UCL Queen Square Institute of Neurology, London, United Kingdom  Kessler Foundation, West Orange, NJ  University of Alabama At Birmingham, Birmingham, AL  Aarhus University, Aarhus, Denmark  Hasselt University, Diepenbeek, Belgium  University of Plymouth, Plymouth, United Kingdom  University of Genoa  IRCCS Ospedale Policlinico San Martino, Genoa, Italy  University of Toronto and Sunnybrook Health Sciences Centre, Toronto, ON, Canada  UT Southwestern Medical Center, Dallas, TX  University of Illinois Chicago, Chicago, IL